dipyridamole has been researched along with Glomerulosclerosis, Focal Segmental in 13 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of the antiplatelet agents aspirin (ASA), dipyridamole (DP) and prostacyclin (PGI2) on glomerulonephritis following Habu snake venom have been investigated." | 3.66 | Focal mesangial proliferative glomerulonephritis in the rat caused by Habu venom: the effect of antiplatelet agents. ( Cattell, V; Mehotra, A, 1980) |
| "Nine cases of nephrotic children associated with focal segmental glomerulosclerosis who had failed to respond to prednisone and cyclophosphamide therapy and showed sign of progressive deterioration of renal function, were subjected to the therapeutic combinations of antiplatelet agents + prednisone +/- anticoagulant agents." | 3.66 | A new therapeutic approach of nephrotic syndrome associated with focal segmental glomerulosclerosis. ( Futrakul, P, 1980) |
| "Dipyridamole was also given at this time." | 1.27 | Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis. ( Zimmerman, SW, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (76.92) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ponticelli, C | 1 |
| Banfi, G | 1 |
| Imbasciati, E | 1 |
| Tarantino, A | 1 |
| Kincaid-Smith, P | 1 |
| Cattell, V | 1 |
| Mehotra, A | 1 |
| Donadio, JV | 1 |
| Futrakul, P | 3 |
| Futrakul, N | 1 |
| Sitprija, V | 1 |
| Sensirivatana, R | 1 |
| Watana, D | 1 |
| Kingwatanakul, P | 1 |
| Kacprzyk, F | 1 |
| Chrzanowski, W | 1 |
| Kubala, L | 1 |
| Orłowski, Z | 1 |
| Fu, LW | 1 |
| Yang, LY | 1 |
| Chen, WP | 1 |
| Tsai, SJ | 1 |
| Lin, CY | 1 |
| Simon, NM | 1 |
| Rosenberg, MJ | 1 |
| Lindeman, RD | 1 |
| Shulutko, BI | 1 |
| Poshyachinda, M | 1 |
| Mitrakul, C | 1 |
| Zimmerman, SW | 1 |
3 reviews available for dipyridamole and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Immunosuppressive therapy in primary glomerulonephritis (pros).
Topics: Adrenocorticotropic Hormone; Azathioprine; Chlorambucil; Cyclophosphamide; Dipyridamole; Glomerulone | 1982 |
Medical treatment of glomerular diseases.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Azathioprine; Child; Chlorambucil; Cyclophosphamid | 1978 |
[Focal glomerulosclerosis (review of the literature and personal observations)].
Topics: Adult; Basement Membrane; Complement System Proteins; Dipyridamole; Female; Glomerulonephritis; Glom | 1979 |
2 trials available for dipyridamole and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
[Results of two year use of dipyridamole and metindol in patients with primary focal and (or) segmental glomerulosclerosis].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dipyridamole; Female; Glomerulosclerosis | 1997 |
IgG subclass/IgM ratio and response to therapy in focal segmental glomerulonecrosis.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Cyclophosphamide; Dipy | 1998 |
8 other studies available for dipyridamole and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
The treatment of glomerulonephritis.
Topics: Adolescent; Cyclophosphamide; Dipyridamole; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; | 1980 |
Focal mesangial proliferative glomerulonephritis in the rat caused by Habu venom: the effect of antiplatelet agents.
Topics: Animals; Aspirin; Blood Platelets; Dipyridamole; Epoprostenol; Glomerulonephritis; Glomerulosclerosi | 1980 |
Primary glomerular disease: to treat or not to treat.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Dipyridamole; Glomerulonephritis; Glomerulosclerosis, | 1982 |
A new therapeutic approach of nephrotic syndrome associated with focal segmental glomerulosclerosis.
Topics: Adolescent; Anticoagulants; Aspirin; Child; Child, Preschool; Cyclophosphamide; Dipyridamole; Drug T | 1980 |
Improved renal perfusion prevents disease progression in focal segmental glomerulosclerosis.
Topics: Cilazapril; Dipyridamole; Disease Progression; Glomerulosclerosis, Focal Segmental; Heparin; Humans; | 1995 |
Drug treatment of the chronic idiopathic glomerulopathies.
Topics: Adrenal Cortex Hormones; Alkylating Agents; B-Lymphocytes; Chronic Disease; Dipyridamole; Folic Acid | 1977 |
Focal sclerosing glomerulonephritis: a kinetic evaluation of hemostasis and the effect of anticoagulant therapy: a controlled study.
Topics: Adolescent; Blood Platelets; Cell Count; Child; Child, Preschool; Cyclophosphamide; Dipyridamole; Dr | 1978 |
Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis.
Topics: Adult; Creatinine; Dipyridamole; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Humans; Ki | 1985 |